Roivant Sciences Ltd. · NASDAQ:ROIV

Venker Eric sold 200,000 Roivant Sciences Ltd. shares (Form 4)

Traded Apr 20, 2026 · Filed Apr 22, 2026

On Apr 20, 2026, Venker Eric (President & Immunovant CEO) sold 200,000 Roivant Sciences Ltd. shares at US$29.59 for US$5.92M under a trading plan, leaving 1,647,546 shares. Filed Apr 22, 2026 (Form 4).

Sold: 200,000 shares
Price: US$29.59
Value: US$5.92M
Holding after: 1,647,546 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President & Immunovant CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Apr 20, 2026	Common Shares	Option exercise	200,000	US$3.85	1,847,546	Direct
Apr 20, 2026	Common Shares	Sale	200,000	US$29.59	1,647,546	Direct

Source

View original at SEC

Related